应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
09926 康方生物
交易中 01-05 11:46:52
117.700
+4.400
+3.88%
最高
118.300
最低
111.000
成交量
463.12万
今开
113.300
昨收
113.300
日振幅
6.44%
总市值
1,084亿
流通市值
1,084亿
总股本
9.21亿
成交额
5.36亿
换手率
0.50%
流通股本
9.21亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
中山全市研发经费投入连续三年超百亿,康方生物7个新药已上市
21世纪经济报道 · 2025-12-31
中山全市研发经费投入连续三年超百亿,康方生物7个新药已上市
每日卖空追踪 | 康方生物 12月30日卖空量成交31.6万股,卖空比例为5.87%
市场透视 · 2025-12-30
每日卖空追踪 | 康方生物 12月30日卖空量成交31.6万股,卖空比例为5.87%
每日卖空追踪 | 康方生物 12月29日卖空量成交24.9万股,卖空比例为4.42%
市场透视 · 2025-12-29
每日卖空追踪 | 康方生物 12月29日卖空量成交24.9万股,卖空比例为4.42%
华海药业HB0025注射液Ⅲ期临床启动,3亿研发加码多靶点抗癌药领域!
摩熵医药大数据 · 2025-12-29
华海药业HB0025注射液Ⅲ期临床启动,3亿研发加码多靶点抗癌药领域!
国产银屑病创新药密集突破!正大天晴重磅1类新药2期临床取得积极结果
制药网 · 2025-12-29
国产银屑病创新药密集突破!正大天晴重磅1类新药2期临床取得积极结果
国内商保发展和集采优化 创新药产业链持续活跃
金证研 · 2025-12-24
国内商保发展和集采优化 创新药产业链持续活跃
每日卖空追踪 | 康方生物 12月24日卖空量成交14.4万股,卖空比例为7%
市场透视 · 2025-12-24
每日卖空追踪 | 康方生物 12月24日卖空量成交14.4万股,卖空比例为7%
康方生物12月24日遭主力抛售36.2万元
市场透视 · 2025-12-24
康方生物12月24日遭主力抛售36.2万元
医药生物行业跟踪周报:银屑病口服TYK2/IL23双雄并立格局确立 建议关注益方生物 诺诚健华 海思科等
东吴证券 · 2025-12-23
医药生物行业跟踪周报:银屑病口服TYK2/IL23双雄并立格局确立 建议关注益方生物 诺诚健华 海思科等
每日卖空追踪 | 康方生物 12月22日卖空量成交18.3万股,卖空比例为5.59%
市场透视 · 2025-12-22
每日卖空追踪 | 康方生物 12月22日卖空量成交18.3万股,卖空比例为5.59%
CTLA4专题:技术革新来临 聚焦“增效减毒”的新一代疗法投资机遇
中泰证券 · 2025-12-22
CTLA4专题:技术革新来临 聚焦“增效减毒”的新一代疗法投资机遇
每日卖空追踪 | 康方生物 12月19日卖空量成交25万股,卖空比例为5.28%
市场透视 · 2025-12-19
每日卖空追踪 | 康方生物 12月19日卖空量成交25万股,卖空比例为5.28%
康方生物12月19日获主力加仓259.6万元
市场透视 · 2025-12-19
康方生物12月19日获主力加仓259.6万元
【券商聚焦】交银国际:临近年末 续看好新BD交易集中落地机会
金吾财讯 · 2025-12-19
【券商聚焦】交银国际:临近年末 续看好新BD交易集中落地机会
每日卖空追踪 | 康方生物 12月17日卖空量成交33.9万股,卖空比例为10.43%
市场透视 · 2025-12-17
每日卖空追踪 | 康方生物 12月17日卖空量成交33.9万股,卖空比例为10.43%
康方生物12月17日获主力加仓617.9万元
市场透视 · 2025-12-17
康方生物12月17日获主力加仓617.9万元
每日卖空追踪 | 康方生物 12月16日卖空量成交34.8万股,卖空比例为7.73%
市场透视 · 2025-12-16
每日卖空追踪 | 康方生物 12月16日卖空量成交34.8万股,卖空比例为7.73%
康方生物12月16日主力净流入300.8万元 散户资金抛售
市场透视 · 2025-12-16
康方生物12月16日主力净流入300.8万元 散户资金抛售
第一上海:予康方生物-B(09926)“买入”评级 目标价为144.9港元
智通财经 · 2025-12-15
第一上海:予康方生物-B(09926)“买入”评级 目标价为144.9港元
午后突发!港股通创新药ETF(520880)跌2.77%创阶段新低,康方生物、百济神州等大权重龙头领跌
新浪基金 · 2025-12-15
午后突发!港股通创新药ETF(520880)跌2.77%创阶段新低,康方生物、百济神州等大权重龙头领跌
加载更多
公司概况
公司名称:
康方生物
所属市场:
SEHK
上市日期:
--
主营业务:
康方生物科技(开曼)有限公司是一家致力于研究、开发、生产及商业化让全球病人可负担的抗体药的投资控股公司。该公司在研项目涵盖肿瘤、自身免疫及代谢性疾病等多个领域。该公司的产品主要包括有用于肿瘤领域的开坦尼(卡度尼利,PD-1/CTLA-4)、依达方(依沃西,PD-1/VEGF)、莱法利(AK117,CD47)、普络西(AK109,VEGFR-2)、安尼可(派安普利,PD-1)、科泰莱(塔戈利单抗,PD-L1)和用于代谢及自免领域的伊喜宁(伊努西单抗,PCSK9)、爱达罗(依若奇单抗,IL-12/IL-23)、古莫奇单抗(AK111,IL-17)。
发行价格:
--
{"stockData":{"symbol":"09926","market":"HK","secType":"STK","nameCN":"康方生物","latestPrice":117.7,"timestamp":1767584767774,"preClose":113.3,"halted":0,"volume":4631204,"delay":0,"floatShares":921000000,"shares":921000000,"eps":-0.6748837448121144,"marketStatus":"交易中","change":4.4,"latestTime":"01-05 11:46:52","open":113.3,"high":118.3,"low":111,"amount":536471686,"amplitude":0.064431,"askPrice":117.8,"askSize":17000,"bidPrice":117.6,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":-1.0790386212376146,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1767585600000},"marketStatusCode":2,"adr":0,"listingDate":1587657600000,"exchange":"SEHK","adjPreClose":113.3,"openAndCloseTimeList":[[1767576600000,1767585600000],[1767589200000,1767600000000]],"volumeRatio":2.656404,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09926","defaultTab":"news","newsList":[{"id":"2595877900","title":"中山全市研发经费投入连续三年超百亿,康方生物7个新药已上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2595877900","media":"21世纪经济报道","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595877900?lang=zh_cn&edition=full","pubTime":"2025-12-31 20:36","pubTimestamp":1767184601,"startTime":"0","endTime":"0","summary":"南方财经21世纪经济报道记者郑全怡广州报道12月31日,“十四五”广东成就系列新闻发布会中山专场在广州召开,详细介绍了“十四五”时期中山市经济社会发展的总体情况和主要成就。“十四五”期间,中山地区生产总值连续跨越3500亿、4000亿元关口,预计2025年将突破4200亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512313607147856.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512313607147856.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1961090484.USD","LU0634319403.HKD","LU2488822045.USD","IE00BPRC5H50.USD","LU2778985437.USD","LU2476274720.SGD","LU0348827113.USD","IE00B5MMRT66.SGD","LU0348735423.USD","LU0540923850.HKD","BK1161","LU0348766576.USD","LU0417516902.SGD","LU2476274308.USD","LU1720050803.USD","LU0348767384.USD","LU0561508036.HKD","LU2399975544.HKD","LU1794554557.SGD","IE00B543WZ88.USD","LU0348825331.USD","LU0417516738.SGD","LU0417516571.SGD","LU0348783233.USD","LU0348784397.USD","BK1574","09926"],"gpt_icon":0},{"id":"2595493207","title":"每日卖空追踪 | 康方生物 12月30日卖空量成交31.6万股,卖空比例为5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595493207","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595493207?lang=zh_cn&edition=full","pubTime":"2025-12-30 16:30","pubTimestamp":1767083441,"startTime":"0","endTime":"0","summary":"康方生物北京时间12月30日,跌0.27%,卖空量成交31.6万股,较上一交易日减少34.85%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163659a6e08047&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163659a6e08047&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348766576.USD","LU0417516902.SGD","09926","IE00B5MMRT66.SGD","LU0348767384.USD","LU0417516571.SGD","BK1161","LU0634319403.HKD","LU2476274308.USD","LU0540923850.HKD","IE00B543WZ88.USD","LU0348825331.USD","LU0348783233.USD","LU1794554557.SGD","LU0561508036.HKD","LU1961090484.USD","IE00BPRC5H50.USD","LU2399975544.HKD","LU2476274720.SGD","LU2488822045.USD","LU1720050803.USD","LU2778985437.USD","LU0417516738.SGD","BK1574","LU0348784397.USD","LU0348735423.USD","LU0348827113.USD"],"gpt_icon":0},{"id":"2595009734","title":"每日卖空追踪 | 康方生物 12月29日卖空量成交24.9万股,卖空比例为4.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595009734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595009734?lang=zh_cn&edition=full","pubTime":"2025-12-29 16:30","pubTimestamp":1766997040,"startTime":"0","endTime":"0","summary":"康方生物北京时间12月29日,跌0.89%,卖空量成交24.9万股,较上一交易日增加72.92%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229163707a4854d76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229163707a4854d76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348783233.USD","LU0348825331.USD","LU0348767384.USD","LU0348784397.USD","LU0417516738.SGD","LU2476274308.USD","LU2399975544.HKD","LU1720050803.USD","BK1161","09926","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","IE00B543WZ88.USD","LU2488822045.USD","LU0561508036.HKD","LU0417516571.SGD","LU0348766576.USD","LU0540923850.HKD","LU0348735423.USD","LU2778985437.USD","BK1574","LU0348827113.USD","LU0634319403.HKD","LU1961090484.USD","LU0417516902.SGD","LU2476274720.SGD","LU1794554557.SGD"],"gpt_icon":0},{"id":"2595973288","title":"华海药业HB0025注射液Ⅲ期临床启动,3亿研发加码多靶点抗癌药领域!","url":"https://stock-news.laohu8.com/highlight/detail?id=2595973288","media":"摩熵医药大数据","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595973288?lang=zh_cn&edition=full","pubTime":"2025-12-29 15:01","pubTimestamp":1766991697,"startTime":"0","endTime":"0","summary":"12月26日,据$华海药业发布公告,其下属子公司上海华奥泰生物的 HB0025 联合化疗一线治疗鳞状和非鳞状非小细胞肺癌经过与国家药品监督管理局药品审评中心Ⅱ期临床试验结束/Ⅲ期临床试验启动前的会议沟通,公司将正式启动 HB0025注射液 的III期临床试验。根据和CDE的会议沟通,华海药业将启动两项确证性III期临床试验。截至目前,华海药业已在 HB0025 项目上已合计投入研发费用约人民币32,597万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229152223a6dc0065&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229152223a6dc0065&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1794554557.SGD","LU0348827113.USD","LU0540923850.HKD","LU0561508036.HKD","LU2476274720.SGD","BK1574","09926","LU2399975544.HKD","LU1961090484.USD","LU0417516738.SGD","LU2488822045.USD","LU2778985437.USD","LU0348735423.USD","LU0417516902.SGD","LU0348784397.USD","IE00B543WZ88.USD","LU0348766576.USD","LU0348767384.USD","BK1161","LU0634319403.HKD","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","LU0417516571.SGD","LU1720050803.USD","LU0348825331.USD","LU2476274308.USD","LU0348783233.USD"],"gpt_icon":0},{"id":"2595673500","title":"国产银屑病创新药密集突破!正大天晴重磅1类新药2期临床取得积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2595673500","media":"制药网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595673500?lang=zh_cn&edition=full","pubTime":"2025-12-29 15:00","pubTimestamp":1766991624,"startTime":"0","endTime":"0","summary":"如中国生物制药于12月29日宣布,正大天晴自主研发的1类创新药TQH3906用于中重度斑块状银屑病的二期临床试验,达到主要研究终点。除了在研药物的稳步推进,国内还有多款治疗中重度斑块状银屑病的创新药已经获批上市。国产银屑病创新药的密集突破,不仅打破了此前临床治疗对进口药物的依赖,更推动我国银屑病治疗进入精准靶向的新时代。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229150230a6dbeecd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229150230a6dbeecd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359202008.SGD","LU0359201612.USD","LU2543165471.USD","LU0359201885.HKD","09926","BK1191","06978","BK1574","01276","BK1161","LU1023057109.AUD"],"gpt_icon":0},{"id":"2593477930","title":"国内商保发展和集采优化 创新药产业链持续活跃","url":"https://stock-news.laohu8.com/highlight/detail?id=2593477930","media":"金证研","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593477930?lang=zh_cn&edition=full","pubTime":"2025-12-24 21:11","pubTimestamp":1766581900,"startTime":"0","endTime":"0","summary":"随着国内商保发展和集采优化,创新药产业链高景气有望延续。当前支持创新药产业发展已成为政策导向,2025年北京、上海、重庆、四川等多地出台相关政策,推动创新药行业高质量发展。近日,2026年医保药品目录和商保药品目录发布,首次在基本医保目录之外增设商保创新药目录。创新药长期产业趋势确定,在国内政策支持以及美联储进入降息周期的背景下,全球创新药研发持续活跃,2026年还有大量BD落地。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224211713a6ca8bf6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224211713a6ca8bf6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0417516902.SGD","LU2488822045.USD","BK1574","01877","IE00B5MMRT66.SGD","LU2778985437.USD","LU1961090484.USD","LU0540923850.HKD","BK1161","LU0348825331.USD","LU2399975544.HKD","IE00BPRC5H50.USD","09926","LU0634319403.HKD","LU0348735423.USD","LU0348783233.USD","01276","LU0348784397.USD","LU0417516571.SGD","LU0561508036.HKD","LU0348767384.USD","ONC","LU2476274720.SGD","01801","06978","LU2476274308.USD","LU0348827113.USD","LU1720050803.USD","LU0417516738.SGD","LU0348766576.USD","LU1794554557.SGD","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"2593477672","title":"每日卖空追踪 | 康方生物 12月24日卖空量成交14.4万股,卖空比例为7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593477672","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593477672?lang=zh_cn&edition=full","pubTime":"2025-12-24 16:30","pubTimestamp":1766565039,"startTime":"0","endTime":"0","summary":"康方生物北京时间12月24日,跌0.62%,卖空量成交14.4万股,较上一交易日减少69.3%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224163649a4728327&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224163649a4728327&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348766576.USD","LU0417516902.SGD","09926","IE00B5MMRT66.SGD","LU0348767384.USD","LU0417516571.SGD","BK1161","LU0634319403.HKD","LU2476274308.USD","LU0540923850.HKD","IE00B543WZ88.USD","LU0348825331.USD","LU0348783233.USD","LU1794554557.SGD","LU0561508036.HKD","LU1961090484.USD","IE00BPRC5H50.USD","LU2399975544.HKD","LU2476274720.SGD","LU2488822045.USD","LU1720050803.USD","LU2778985437.USD","LU0417516738.SGD","BK1574","LU0348784397.USD","LU0348735423.USD","LU0348827113.USD"],"gpt_icon":0},{"id":"2593477955","title":"康方生物12月24日遭主力抛售36.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593477955","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593477955?lang=zh_cn&edition=full","pubTime":"2025-12-24 16:15","pubTimestamp":1766564151,"startTime":"0","endTime":"0","summary":"12月24日, 康方生物股价跌0.62%,报收112.60元,成交金额2.3亿元,换手率0.22%,振幅1.94%,量比0.60。康方生物今日主力资金净流出36.2万元,上一交易日主力净流出1400.8万元。该股近5个交易日下跌3.84%,主力资金累计净流出131.5万元;近20日主力资金累计净流入1416.4万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224162053a4726f87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224162053a4726f87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B543WZ88.USD","LU0540923850.HKD","09926","LU2778985437.USD","LU2399975544.HKD","LU1961090484.USD","LU0417516902.SGD","LU2476274720.SGD","LU0417516571.SGD","LU2476274308.USD","LU0561508036.HKD","LU2488822045.USD","IE00BPRC5H50.USD","LU0634319403.HKD","IE00B5MMRT66.SGD","LU0348827113.USD","LU0348767384.USD","LU1794554557.SGD","LU0348784397.USD","LU0348766576.USD","BK1574","BK1161","LU1720050803.USD","LU0348783233.USD","LU0417516738.SGD","LU0348825331.USD","LU0348735423.USD"],"gpt_icon":0},{"id":"2593463647","title":"医药生物行业跟踪周报:银屑病口服TYK2/IL23双雄并立格局确立 建议关注益方生物 诺诚健华 海思科等","url":"https://stock-news.laohu8.com/highlight/detail?id=2593463647","media":"东吴证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593463647?lang=zh_cn&edition=full","pubTime":"2025-12-23 00:00","pubTimestamp":1766419200,"startTime":"0","endTime":"0","summary":"2025 年12 月18 日,济民可信集团宣布,其申报的2.2 类及2.4 类新药JMX-2005 注射液已获国家药品监督管理局批准开展临床试验。随着武田新一代TYK2 抑制剂Zasocitinib 三期临床阳性顶线数据的出炉,叠加强生口服IL23 受体拮抗剂Icotrokinra 关键三期研究数据的持续兑现,银屑病口服治疗领域TYK2/IL23 双雄并立的格局正式确立。建议关注在TYK2 赛道具备差异化竞争优势的公司:如益方生物、诺诚健华等,以及布局口服IL23 相关领域的公司:如海思科等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223071133a6c31d0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223071133a6c31d0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09926","03933","BK1161","01801","BK1574","09969","01276","02615"],"gpt_icon":0},{"id":"2593489464","title":"每日卖空追踪 | 康方生物 12月22日卖空量成交18.3万股,卖空比例为5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593489464","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593489464?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:30","pubTimestamp":1766392242,"startTime":"0","endTime":"0","summary":"康方生物北京时间12月22日,跌1.71%,卖空量成交18.3万股,较上一交易日减少77.52%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163708a469985f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163708a469985f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BPRC5H50.USD","09926","IE00B543WZ88.USD","LU2399975544.HKD","LU0634319403.HKD","LU1720050803.USD","LU0348827113.USD","LU1794554557.SGD","LU0348784397.USD","LU2476274308.USD","BK1574","LU1961090484.USD","LU0348767384.USD","LU0348735423.USD","LU0348825331.USD","LU0417516738.SGD","LU0348766576.USD","LU0561508036.HKD","LU2488822045.USD","LU2778985437.USD","BK1161","LU0417516902.SGD","LU2476274720.SGD","LU0540923850.HKD","LU0417516571.SGD","IE00B5MMRT66.SGD","LU0348783233.USD"],"gpt_icon":0},{"id":"2593107812","title":"CTLA4专题:技术革新来临 聚焦“增效减毒”的新一代疗法投资机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2593107812","media":"中泰证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593107812?lang=zh_cn&edition=full","pubTime":"2025-12-22 00:00","pubTimestamp":1766332800,"startTime":"0","endTime":"0","summary":"新版“医保+商保”双目录已于近期发布并将在2026 年1 月1 日正式实施。多特异性抗体与ADC,这是当前创新药研发最火热的领域之一。CTLA-4 专题:CTLA-4 赛道迎来技术革新,聚焦“增效减毒”的新一代疗法投资机遇。新一代CTLA-4 药物通过技术创新,正在解决该靶点商业化最大的障碍——毒性问题,从而有望释放其市场潜力。PD-1/PD-L1 抑制剂已成为多种癌症的一线标准疗法,但耐药性是随之而来的临床难题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222143131a6c01da6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222143131a6c01da6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","LU0634319403.HKD","LU0348766576.USD","LU2476274308.USD","LU0561508036.HKD","ADAG","LU0348827113.USD","BK1161","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","LU1961090484.USD","LU0348767384.USD","LU2476274720.SGD","02616","09926","LU2488822045.USD","LU2778985437.USD","LU0417516902.SGD","LU2399975544.HKD","IE00B543WZ88.USD","LU1720050803.USD","LU0348783233.USD","LU1794554557.SGD","BK1574","LU0540923850.HKD","LU0417516738.SGD","LU0348784397.USD","09939","LU0348825331.USD","LU0348735423.USD","LU0417516571.SGD"],"gpt_icon":0},{"id":"2592192884","title":"每日卖空追踪 | 康方生物 12月19日卖空量成交25万股,卖空比例为5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592192884","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592192884?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:30","pubTimestamp":1766133041,"startTime":"0","endTime":"0","summary":"康方生物北京时间12月19日,涨1.12%,卖空量成交25万股,较上一交易日减少29.97%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163701a6b64843&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163701a6b64843&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1961090484.USD","LU2778985437.USD","LU1720050803.USD","LU0348825331.USD","LU0348767384.USD","BK1574","LU0417516738.SGD","LU0348784397.USD","LU2488822045.USD","LU0348735423.USD","BK1161","IE00BPRC5H50.USD","IE00B543WZ88.USD","09926","LU0348827113.USD","LU0417516571.SGD","LU0634319403.HKD","LU0348766576.USD","LU2399975544.HKD","LU2476274308.USD","LU0417516902.SGD","LU0540923850.HKD","LU1794554557.SGD","LU0348783233.USD","LU2476274720.SGD","IE00B5MMRT66.SGD","LU0561508036.HKD"],"gpt_icon":0},{"id":"2592192887","title":"康方生物12月19日获主力加仓259.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592192887","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592192887?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:15","pubTimestamp":1766132118,"startTime":"0","endTime":"0","summary":"12月19日, 康方生物股价涨1.12%,报收117.20元,成交金额5.6亿元,换手率0.51%,振幅5.26%,量比0.74。康方生物今日主力资金净流入259.6万元,连续4日净流入,上一交易日主力净流入438.3万元。近一年数据显示,该股主力连续4日净流入后,次日上涨概率为62.50%,平均涨幅为3.50%。该股近5个交易日下跌4.58%,主力资金累计净流出8028.9万元;近20日主力资金累计净流入1.4亿元,其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219161623a6b62e5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219161623a6b62e5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348766576.USD","LU0417516902.SGD","09926","IE00B5MMRT66.SGD","LU0348767384.USD","LU0417516571.SGD","BK1161","LU0634319403.HKD","LU2476274308.USD","LU0540923850.HKD","IE00B543WZ88.USD","LU0348825331.USD","LU0348783233.USD","LU1794554557.SGD","LU0561508036.HKD","LU1961090484.USD","IE00BPRC5H50.USD","LU2399975544.HKD","LU2476274720.SGD","LU2488822045.USD","LU1720050803.USD","LU2778985437.USD","LU0417516738.SGD","BK1574","LU0348784397.USD","LU0348735423.USD","LU0348827113.USD"],"gpt_icon":0},{"id":"2592513686","title":"【券商聚焦】交银国际:临近年末 续看好新BD交易集中落地机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2592513686","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592513686?lang=zh_cn&edition=full","pubTime":"2025-12-19 09:20","pubTimestamp":1766107245,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发布医药行业周报,本周多项超10亿美元的BD交易相继落地,合作伙伴既有MNC也有中小型生物科技公司。临近年末,该机构继续看好新BD交易集中落地机会。展望2026 年,该机构认为板块稳中向好态势延续,但影响市场表现的核心因素或呈分化态势,后续选股逻辑或将重回基本面和估值,即关注存在基本面预期差、当前仍被低估的个股。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/YzM1MzBiNWM5MmUxNDYxMGFiODk0MWI5MWJmNTU3YjMxMTA4MTkwNzI1ODY3.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YzM1MzBiNWM5MmUxNDYxMGFiODk0MWI5MWJmNTU3YjMxMTA4MTkwNzI1ODY3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971853","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1147","LU0634319403.HKD","LU2488822045.USD","LU0307460666.USD","BK1593","LU2778985437.USD","LU0417516571.SGD","LU1720050803.USD","LU2328871848.SGD","LU0561508036.HKD","03329","HK0000165453.HKD","LU1303224171.USD","01099","09926","LU0348766576.USD","02268","IE00B543WZ88.USD","LU2476274720.SGD","LU0540923850.HKD","LU2476274308.USD","02196","BK1583","IE00B5MMRT66.SGD","BK1191","LU0348783233.USD","LU1115378108.SGD","02228","01530","01789","SG9999014674.SGD","06160","BK1585","BK1500","LU0588546209.SGD","LU1794554557.SGD","BK1197","09688","LU1251922891.USD","LU0417516738.SGD","03933","LU0348825331.USD","LU2399975544.HKD","LU1770034418.SGD","LU0348735423.USD","BK1588","LU0348784397.USD","BK1617","02367","LU0417516902.SGD"],"gpt_icon":0},{"id":"2592910404","title":"每日卖空追踪 | 康方生物 12月17日卖空量成交33.9万股,卖空比例为10.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592910404","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592910404?lang=zh_cn&edition=full","pubTime":"2025-12-17 16:30","pubTimestamp":1765960241,"startTime":"0","endTime":"0","summary":"康方生物北京时间12月17日,涨0.17%,卖空量成交33.9万股,较上一交易日减少66.3%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163653a45615ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163653a45615ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348735423.USD","LU2476274720.SGD","LU1961090484.USD","LU0348766576.USD","LU0540923850.HKD","LU2778985437.USD","LU0634319403.HKD","LU0417516902.SGD","LU0348784397.USD","LU0561508036.HKD","LU2399975544.HKD","LU1794554557.SGD","IE00B543WZ88.USD","LU0348825331.USD","BK1574","LU0348783233.USD","LU0417516738.SGD","09926","LU0417516571.SGD","LU2488822045.USD","LU1720050803.USD","LU2476274308.USD","LU0348827113.USD","IE00B5MMRT66.SGD","BK1161","LU0348767384.USD","IE00BPRC5H50.USD"],"gpt_icon":0},{"id":"2592910473","title":"康方生物12月17日获主力加仓617.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592910473","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592910473?lang=zh_cn&edition=full","pubTime":"2025-12-17 16:15","pubTimestamp":1765959324,"startTime":"0","endTime":"0","summary":"12月17日, 康方生物股价涨0.17%,报收117.10元,成交金额3.8亿元,换手率0.35%,振幅3.17%,量比0.45。康方生物今日主力资金净流入617.9万元,上一交易日主力净流入300.8万元。该股近5个交易日上涨0.60%,主力资金累计净流入1739.8万元;近20日主力资金累计净流入1.2亿元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217161647a6ad1054&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217161647a6ad1054&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0561508036.HKD","LU1720050803.USD","IE00B543WZ88.USD","LU0417516738.SGD","LU0540923850.HKD","LU2476274720.SGD","BK1574","IE00BPRC5H50.USD","LU2399975544.HKD","LU0348767384.USD","09926","LU0417516902.SGD","IE00B5MMRT66.SGD","LU2778985437.USD","LU0348825331.USD","LU0348735423.USD","LU0634319403.HKD","LU0348783233.USD","LU2476274308.USD","LU1794554557.SGD","LU2488822045.USD","LU0348766576.USD","BK1161","LU0348827113.USD","LU0348784397.USD","LU0417516571.SGD","LU1961090484.USD"],"gpt_icon":0},{"id":"2592970931","title":"每日卖空追踪 | 康方生物 12月16日卖空量成交34.8万股,卖空比例为7.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592970931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592970931?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:30","pubTimestamp":1765873839,"startTime":"0","endTime":"0","summary":"康方生物北京时间12月16日,涨0.6%,卖空量成交34.8万股,较上一交易日减少89.69%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163638a451a178&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163638a451a178&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348784397.USD","LU0540923850.HKD","LU2778985437.USD","IE00B5MMRT66.SGD","LU0348825331.USD","BK1161","LU0348767384.USD","LU0348766576.USD","LU0561508036.HKD","IE00BPRC5H50.USD","LU0417516571.SGD","LU2476274308.USD","LU0348735423.USD","LU1794554557.SGD","LU2399975544.HKD","LU2476274720.SGD","LU1720050803.USD","LU0417516902.SGD","09926","LU0348783233.USD","LU2488822045.USD","LU0634319403.HKD","LU1961090484.USD","LU0417516738.SGD","LU0348827113.USD","BK1574","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"2592319739","title":"康方生物12月16日主力净流入300.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2592319739","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592319739?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:15","pubTimestamp":1765872923,"startTime":"0","endTime":"0","summary":"12月16日, 康方生物股价涨0.60%,报收116.90元,成交金额5.2亿元,换手率0.49%,振幅3.96%,量比0.54。康方生物今日主力资金净流入300.8万元,上一交易日主力净流出9645.4万元。该股近5个交易日下跌1.84%,主力资金累计净流入1957.4万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入1.1亿元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216161650a6a8a17c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216161650a6a8a17c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1794554557.SGD","LU0348766576.USD","LU1961090484.USD","LU0540923850.HKD","LU2399975544.HKD","LU0348825331.USD","LU0348735423.USD","IE00BPRC5H50.USD","09926","LU2488822045.USD","LU2778985437.USD","LU0417516738.SGD","IE00B5MMRT66.SGD","LU2476274720.SGD","LU0348783233.USD","LU0634319403.HKD","LU0417516902.SGD","BK1161","LU0417516571.SGD","IE00B543WZ88.USD","LU0348784397.USD","LU0348827113.USD","LU0348767384.USD","BK1574","LU2476274308.USD","LU1720050803.USD","LU0561508036.HKD"],"gpt_icon":0},{"id":"2591616752","title":"第一上海:予康方生物-B(09926)“买入”评级 目标价为144.9港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2591616752","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591616752?lang=zh_cn&edition=full","pubTime":"2025-12-15 15:50","pubTimestamp":1765785004,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,第一上海发布研报称,康方生物-B在核心产品管线方面取得多项进展。以DCF估值法,得出目标价144.9港元,较现价有23.4%上升空间,买入评级。第一上海主要观点如下:财务表现2025年上半年,康方生物产品收入同比增长49.2%至14.0亿元,加上许可费收入,公司录得总收入14.1亿元,毛利率为79.4%,研发开支增长23.0%至7.3亿元。2025年8月底,公司以每股149.54港元的价格配售23.55亿股,获得净融资额34.93亿港元,预计配售后公司在手净现金为58亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381489.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00227","09926"],"gpt_icon":0},{"id":"2591697904","title":"午后突发!港股通创新药ETF(520880)跌2.77%创阶段新低,康方生物、百济神州等大权重龙头领跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2591697904","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591697904?lang=zh_cn&edition=full","pubTime":"2025-12-15 13:39","pubTimestamp":1765777140,"startTime":"0","endTime":"0","summary":"12月15日午后,港股通创新药板块加速下跌,港股通创新药ETF一度跌至2.77%创近5个月新低,龙头股齐挫,康方生物跌超5%,百济神州跌逾6%,中国生物制药、信达生物跌超3%。 阶段新低之际,“抄底”资金或再行动,港股通创新药ETF场内宽幅溢价,显示买盘资金相对强势。 把握港股创新药低吸窗口期,认准同类最大港股通创新药ETF及其场外联接基金,标的指数恒生港股通创新药精选指数具备三大独特优势:","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2025-12-15/doc-inhawauf3976382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0348827113.USD","LU0588546209.SGD","BK1574","09926","LU2328871848.SGD","LU1961090484.USD","LU0348767384.USD","BK1500","LU0348735423.USD","520880","LU1720050803.USD","LU2476274720.SGD","LU1794554557.SGD","LU0417516738.SGD","BK4139","LU0348766576.USD","LU0540923850.HKD","LU1719994722.HKD","LU2399975544.HKD","IE00B543WZ88.USD","06160","LU0417516902.SGD","LU0348783233.USD","BK1588","BK4585","LU0348784397.USD","688235","LU0561508036.HKD","BK4526","LU1969619763.USD","LU1770034418.SGD","ONC","LU2488822045.USD","LU2476274308.USD","BK1161","LU2778985437.USD","IE00BPRC5H50.USD","LU1303224171.USD","LU0634319403.HKD","LU0348825331.USD","LU1251922891.USD","IE00B5MMRT66.SGD","LU0417516571.SGD","BK0239","LU0307460666.USD","BK1583"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.akesobio.com","stockEarnings":[{"period":"1week","weight":0.0062},{"period":"1month","weight":-0.0415},{"period":"3month","weight":-0.1896},{"period":"6month","weight":-0.0241},{"period":"1year","weight":0.9334},{"period":"ytd","weight":0.0027}],"compareEarnings":[{"period":"1week","weight":0.0201},{"period":"1month","weight":0.0224},{"period":"3month","weight":-0.0296},{"period":"6month","weight":0.1013},{"period":"1year","weight":0.3422},{"period":"ytd","weight":0.0276}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康方生物科技(开曼)有限公司是一家致力于研究、开发、生产及商业化让全球病人可负担的抗体药的投资控股公司。该公司在研项目涵盖肿瘤、自身免疫及代谢性疾病等多个领域。该公司的产品主要包括有用于肿瘤领域的开坦尼(卡度尼利,PD-1/CTLA-4)、依达方(依沃西,PD-1/VEGF)、莱法利(AK117,CD47)、普络西(AK109,VEGFR-2)、安尼可(派安普利,PD-1)、科泰莱(塔戈利单抗,PD-L1)和用于代谢及自免领域的伊喜宁(伊努西单抗,PCSK9)、爱达罗(依若奇单抗,IL-12/IL-23)、古莫奇单抗(AK111,IL-17)。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.000939},{"month":2,"riseRate":0.4,"avgChangeRate":0.029178},{"month":3,"riseRate":0.4,"avgChangeRate":-0.035342},{"month":4,"riseRate":0.8,"avgChangeRate":0.041218},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.003133},{"month":6,"riseRate":0.666667,"avgChangeRate":0.133235},{"month":7,"riseRate":0.5,"avgChangeRate":0.087867},{"month":8,"riseRate":0.5,"avgChangeRate":-0.007754},{"month":9,"riseRate":0.5,"avgChangeRate":0.036209},{"month":10,"riseRate":0.5,"avgChangeRate":0.046029},{"month":11,"riseRate":1,"avgChangeRate":0.102206},{"month":12,"riseRate":0.333333,"avgChangeRate":0.028279}],"exchange":"SEHK","name":"康方生物","nameEN":"AKESO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康方生物(09926)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康方生物(09926)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康方生物,09926,康方生物股票,康方生物股票老虎,康方生物股票老虎国际,康方生物行情,康方生物股票行情,康方生物股价,康方生物股市,康方生物股票价格,康方生物股票交易,康方生物股票购买,康方生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康方生物(09926)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康方生物(09926)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}